Caroline Chen

Reporter

Photo of Caroline Chen

Caroline Chen covers health care for ProPublica. She is currently reporting on the coronavirus pandemic.

Her 2019 stories on a heart transplant program in New Jersey that prioritized metrics over patient care won the Livingston Award for local reporting. Her story on racial disparities in cancer clinical trials with Riley Wong in 2018 won the June L. Biedler Cancer Prize for Cancer Journalism in online/multimedia reporting.

Previously, she worked at Bloomberg News, where her coverage included the unraveling of blood test maker Theranos and the 2014 Ebola outbreak. She received her Master’s degree from the Stabile Program in Investigative Journalism at Columbia University, where she was awarded a Pulitzer Traveling Fellowship.

Barreras falsas: estas cosas no deberían impedirle vacunarse contra COVID-19

Se supone que las vacunas contra el coronavirus son gratuitas y están disponibles para todos en Estados Unidos, independientemente de su seguro o de su situación migratoria. Para algunos, no ha sido así.

False Barriers: These Things Should Not Prevent You From Getting a COVID Vaccine

Vaccinations for the coronavirus are supposed to be free and available to all Americans regardless of insurance or immigration status. For some, that isn’t how it has been playing out. Here are common false barriers to look out for.

Ayúdenos con nuestros reportajes sobre la vacuna contra COVID-19

El desarrollo y la distribución de una vacuna afectará a todos los habitantes del planeta. Ayúdenos a identificar historias importantes para poder contarlas.

What ProPublica Is Doing About Diversity in 2021

Here is our annual report on the breakdown of our staff and how we’re working to create a more diverse news organization and inclusive journalism community.

Cómo se incorpora la inequidad en el sistema de vacunación de Estados Unidos

Las personas que reúnen los requisitos para recibir la vacuna contra el coronavirus nos dicen que se están topando con barreras que están diseñadas en los mismos sistemas destinados a atender a las personas con mayor riesgo de morir por la enfermedad. Tenemos previsto continuar el seguimiento de estos obstáculos.

How Inequity Gets Built Into America’s Vaccination System

People eligible for the coronavirus vaccine tell us they are running up against barriers that are designed into the very systems meant to serve those most at risk of dying of the disease. We plan to continue tracking these roadblocks.

Fauci: Vaccines for Kids as Young as First Graders Could Be Authorized by September

For this to happen by the start of the next school year, trials need to prove the vaccine is safe and effective in children. Experts say manufacturers aren’t moving quickly enough, and that this is important for achieving herd immunity and stopping the spread of variants.

Why Opening Restaurants Is Exactly What the Coronavirus Wants Us to Do

Governors continue to open indoor dining and other activities before vaccinations become widespread. Experts warn this could create superspreading playgrounds for dangerous variants and squander our best shot at getting the pandemic under control.

How Many Vaccine Shots Go to Waste? Several States Aren’t Counting.

The CDC says health facilities should report unused and spoiled COVID-19 vaccines, but many are failing to do so. At a time when there aren’t enough shots to meet demand, significant numbers may be going in the trash.

How Operation Warp Speed Created Vaccination Chaos

States are struggling to plan their vaccination programs with just one week’s notice for how many doses they’ll receive from the federal government. The incoming Biden administration is deciding what to do with this dysfunctional system.

Only Seven of Stanford’s First 5,000 Vaccines Were Designated for Medical Residents

Stanford Medicine officials relied on a faulty algorithm to determine who should get vaccinated first, and it prioritized some high-ranking doctors over patient-facing medical residents.

Vaccinating Black Americans Is Essential. Key States Aren’t Doing the Work to Combat Hesitancy

States and the federal government also don’t reliably collect data so we won’t have a good idea of whether the vaccine is reaching these critical populations.

The Enraging Deja Vu of a Third Coronavirus Wave

Health care workers don’t need patronizing praise. They need resources, federal support, and for us to stay healthy and out of their hospitals. In many cases, none of that is happening.

Most States Aren’t Ready to Distribute the Leading COVID-19 Vaccine

A review of state distribution plans reveals that officials don’t know how they’ll deal with the difficult storage and transport requirements of Pfizer’s vaccine, especially in the rural areas currently seeing a spike in infections.

Electionland de ProPublica: El estado del Día de las Elecciones de 2020

En una elección histórica marcada por una pandemia, el voto por correo y la desinformación, los funcionarios electorales se esfuerzan por adaptarse. Esto es lo que los reporteros nacionales de ProPublica están viendo en todo el país. El artículo será actualizado a lo largo del día

ProPublica’s Electionland: The State of Election Day 2020

In a historic election shaped by a pandemic, mail-in voting and misinformation, election officials are scrambling to adapt. Here’s what ProPublica’s national reporters are seeing across the country. This post will be updated throughout the day.

Leader of Newark Beth Israel’s Troubled Heart Transplant Program Departs

Dr. Mark Zucker was put on administrative leave after ProPublica showed he told staff to keep a heart transplant patient on life support because of concerns about survival stats. Now Newark Beth Israel will seek a new leader for the program.

Who Decides When Vaccine Studies Are Done? Internal Documents Show Fauci Plays a Key Role.

Dr. Anthony Fauci will see data from government-funded vaccine trials before the FDA does. One caveat: Pfizer’s study, which is ahead of the others, isn’t included in his purview.

How to Tell a Political Stunt From a Real Vaccine

There is a small chance that Pfizer’s vaccine trial will yield results by Nov. 3. But it could still take weeks for FDA review. Here’s everything that has to happen and how to tell a political stunt from a real vaccine.

Help Us Report on COVID-19 Vaccines

The development and deployment of a vaccine will affect everybody on the planet. Help us identify and tell important stories.

Follow ProPublica

Latest Stories from ProPublica